Diagnostic Frequency Ratios Are Insufficient to Measure Laboratory Precision with the Bethesda System for Reporting Thyroid Cytopathology

Roghayeh Fazeli, Eric B. Schneider, Syed Z Ali, Martha A. Zeiger, Matthew T. Olson

Research output: Contribution to journalArticle

Abstract

Objective: Diagnostic frequency ratios such as the atypia of undetermined significance (AUS):malignant ratio are touted to be useful for laboratory precision benchmarking. We therefore sought to examine their reproducibility and usefulness at a tertiary hospital. Methods: We reviewed thyroid fine-needle aspirates (FNA) submitted to our institution from outside laboratories and evaluated the ability of diagnostic frequency ratios to capture the complexity of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Specifically, we evaluated the ability of the AUS:malignant ratio to describe the frequencies of the other TBSRTC diagnoses. Results: A total of 2,784 cases from 19 laboratories were included. The use of the AUS category varied the most. There was insufficient reflection of the non-AUS nonmalignant TBSRTC diagnostic frequencies in our analysis, and these results do not appear to arise from observer variability in the outside laboratories. Conclusion: Diagnostic frequency ratios are not reproducible in our experience and fail to describe the other TBSRTC categories. As such, they are unlikely to prove sufficient for benchmarking laboratory precision with TBSRTC.

Original languageEnglish (US)
Pages (from-to)225-232
Number of pages8
JournalActa Cytologica
Volume59
DOIs
StatePublished - Sep 1 2015

Fingerprint

Thyroid Gland
Benchmarking
Tertiary Care Centers
Needles

Keywords

  • Atypia of undetermined significance
  • Fine-needle aspiration
  • Quality assurance
  • The Bethesda System for Reporting Thyroid Cytopathology
  • Thyroid cytopathology

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Medicine(all)

Cite this

Diagnostic Frequency Ratios Are Insufficient to Measure Laboratory Precision with the Bethesda System for Reporting Thyroid Cytopathology. / Fazeli, Roghayeh; Schneider, Eric B.; Ali, Syed Z; Zeiger, Martha A.; Olson, Matthew T.

In: Acta Cytologica, Vol. 59, 01.09.2015, p. 225-232.

Research output: Contribution to journalArticle

Fazeli, Roghayeh ; Schneider, Eric B. ; Ali, Syed Z ; Zeiger, Martha A. ; Olson, Matthew T. / Diagnostic Frequency Ratios Are Insufficient to Measure Laboratory Precision with the Bethesda System for Reporting Thyroid Cytopathology. In: Acta Cytologica. 2015 ; Vol. 59. pp. 225-232.
@article{3adee39e06d24d048860d339c70aca38,
title = "Diagnostic Frequency Ratios Are Insufficient to Measure Laboratory Precision with the Bethesda System for Reporting Thyroid Cytopathology",
abstract = "Objective: Diagnostic frequency ratios such as the atypia of undetermined significance (AUS):malignant ratio are touted to be useful for laboratory precision benchmarking. We therefore sought to examine their reproducibility and usefulness at a tertiary hospital. Methods: We reviewed thyroid fine-needle aspirates (FNA) submitted to our institution from outside laboratories and evaluated the ability of diagnostic frequency ratios to capture the complexity of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Specifically, we evaluated the ability of the AUS:malignant ratio to describe the frequencies of the other TBSRTC diagnoses. Results: A total of 2,784 cases from 19 laboratories were included. The use of the AUS category varied the most. There was insufficient reflection of the non-AUS nonmalignant TBSRTC diagnostic frequencies in our analysis, and these results do not appear to arise from observer variability in the outside laboratories. Conclusion: Diagnostic frequency ratios are not reproducible in our experience and fail to describe the other TBSRTC categories. As such, they are unlikely to prove sufficient for benchmarking laboratory precision with TBSRTC.",
keywords = "Atypia of undetermined significance, Fine-needle aspiration, Quality assurance, The Bethesda System for Reporting Thyroid Cytopathology, Thyroid cytopathology",
author = "Roghayeh Fazeli and Schneider, {Eric B.} and Ali, {Syed Z} and Zeiger, {Martha A.} and Olson, {Matthew T.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1159/000379738",
language = "English (US)",
volume = "59",
pages = "225--232",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",

}

TY - JOUR

T1 - Diagnostic Frequency Ratios Are Insufficient to Measure Laboratory Precision with the Bethesda System for Reporting Thyroid Cytopathology

AU - Fazeli, Roghayeh

AU - Schneider, Eric B.

AU - Ali, Syed Z

AU - Zeiger, Martha A.

AU - Olson, Matthew T.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Objective: Diagnostic frequency ratios such as the atypia of undetermined significance (AUS):malignant ratio are touted to be useful for laboratory precision benchmarking. We therefore sought to examine their reproducibility and usefulness at a tertiary hospital. Methods: We reviewed thyroid fine-needle aspirates (FNA) submitted to our institution from outside laboratories and evaluated the ability of diagnostic frequency ratios to capture the complexity of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Specifically, we evaluated the ability of the AUS:malignant ratio to describe the frequencies of the other TBSRTC diagnoses. Results: A total of 2,784 cases from 19 laboratories were included. The use of the AUS category varied the most. There was insufficient reflection of the non-AUS nonmalignant TBSRTC diagnostic frequencies in our analysis, and these results do not appear to arise from observer variability in the outside laboratories. Conclusion: Diagnostic frequency ratios are not reproducible in our experience and fail to describe the other TBSRTC categories. As such, they are unlikely to prove sufficient for benchmarking laboratory precision with TBSRTC.

AB - Objective: Diagnostic frequency ratios such as the atypia of undetermined significance (AUS):malignant ratio are touted to be useful for laboratory precision benchmarking. We therefore sought to examine their reproducibility and usefulness at a tertiary hospital. Methods: We reviewed thyroid fine-needle aspirates (FNA) submitted to our institution from outside laboratories and evaluated the ability of diagnostic frequency ratios to capture the complexity of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Specifically, we evaluated the ability of the AUS:malignant ratio to describe the frequencies of the other TBSRTC diagnoses. Results: A total of 2,784 cases from 19 laboratories were included. The use of the AUS category varied the most. There was insufficient reflection of the non-AUS nonmalignant TBSRTC diagnostic frequencies in our analysis, and these results do not appear to arise from observer variability in the outside laboratories. Conclusion: Diagnostic frequency ratios are not reproducible in our experience and fail to describe the other TBSRTC categories. As such, they are unlikely to prove sufficient for benchmarking laboratory precision with TBSRTC.

KW - Atypia of undetermined significance

KW - Fine-needle aspiration

KW - Quality assurance

KW - The Bethesda System for Reporting Thyroid Cytopathology

KW - Thyroid cytopathology

UR - http://www.scopus.com/inward/record.url?scp=84941934462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941934462&partnerID=8YFLogxK

U2 - 10.1159/000379738

DO - 10.1159/000379738

M3 - Article

C2 - 26022342

AN - SCOPUS:84941934462

VL - 59

SP - 225

EP - 232

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

ER -